RPS25 antibodies are polyclonal reagents designed to detect ribosomal protein S25, a component of the 40S ribosomal subunit involved in mRNA translation. These antibodies are critical for studying viral replication mechanisms (e.g., hepatitis C virus) and diseases like cancer and neurodegenerative disorders .
| Property | Details |
|---|---|
| Target | Ribosomal protein S25 (RPS25) |
| Host Species | Rabbit |
| Isotype | IgG |
| Tested Applications | WB, IHC, IF/ICC, ELISA |
| Observed Molecular Weight | 15–17 kDa |
| Reactivity | Human, Mouse, Rat (varies by product) |
RPS25 is essential for hepatitis C virus (HCV) and Dicistroviridae replication by facilitating ribosomal recruitment to viral internal ribosome entry sites (IRES) .
CRISPR-Cas9 knockout of RPS25 in Hap1 cells reduced HCV IRES-mediated translation by 50% without significantly affecting global protein synthesis .
RPS25 regulates repeat-associated non-AUG (RAN) translation in C9orf72-linked ALS/FTD. Depletion of RPS25 in Drosophila and human cell models reduced toxic dipeptide production (poly-GP, poly-GA) by 50–90% .
In FXTAS models, RPS25 silencing repressed FMRpolyG biosynthesis, suggesting its role in modulating CGG repeat-associated toxicity .
RPS25 is overexpressed in adriamycin-resistant leukemia cells and implicated in p53-mediated apoptosis .
Validated in breast cancer, liver cancer, and lung adenocarcinoma tissues via IHC .
RPS25 is a eukaryotic-specific, non-essential protein component of the small (40S) ribosomal subunit that plays critical roles in several forms of unconventional translation. It is particularly significant because it mediates the direct recruitment of the 40S ribosomal subunit to specific viral IRES (Internal Ribosome Entry Site) RNAs and regulates translation initiation of various viral RNAs downstream of 40S subunit recruitment . Additionally, RPS25 regulates several cellular IRES-containing RNAs including p53 and c-myc . Recent research has revealed its essential role in RAN (Repeat-Associated Non-AUG) translation of nucleotide repeat expansions associated with neurodegenerative diseases, making it a potentially valuable therapeutic target .
Commercial RPS25 antibodies have been validated for multiple research applications. Based on available data, these antibodies are particularly suitable for:
Western Blotting (WB): Typically at dilutions of 1:1,000 to 1:10,000, depending on the specific antibody
Immunohistochemistry (IHC): Effective at dilutions ranging from 1:50 to 1:500
Immunocytochemistry (ICC) and Immunofluorescence (IF): Usually at dilutions of 1:20 to 1:200
Affinity binding assays: For detecting interactions between RPS25 and other molecules
Different antibody clones may show varying levels of effectiveness across these applications, so validation in your specific experimental system is recommended .
Confirming antibody specificity is crucial for reliable experimental results. For RPS25 antibodies, researchers typically employ the following validation methods:
Western blotting in multiple cell lines (such as A549, HeLa, K-562, and MCF-7) to verify detection of the expected 15-17 kDa band
Comparative analysis in RPS25 knockout vs. wildtype cells to confirm signal reduction or elimination in knockout samples
Affinity binding assays with recombinant RPS25 protein to determine binding kinetics and specificity (typical high-affinity antibodies show KD values in the nanomolar range, e.g., 4.7 × 10⁻⁷ M)
Cross-reactivity testing across species to determine conservation of the epitope recognition
Immunohistochemical validation in tissues known to express RPS25, such as human tonsil, breast, or liver tissue
For optimal detection of RPS25 across different experimental platforms, consider these methodological recommendations:
For challenging samples or specialized applications, optimization of these conditions may be necessary to maximize signal-to-noise ratio and ensure reproducibility.
RPS25 antibodies provide powerful tools for investigating unconventional translation mechanisms such as IRES-mediated translation and ribosome shunting. Methodological approaches include:
Ribosome profiling with RPS25 immunoprecipitation: This approach allows researchers to isolate RPS25-containing ribosomes and analyze associated mRNAs, revealing which transcripts depend on RPS25 for translation. Analysis of ribosome-protected fragment lengths can distinguish between canonical and unconventional translation events .
Polysome profiling combined with RPS25 detection: By fractionating polysomes and analyzing RPS25 distribution alongside specific mRNAs, researchers can determine which translation complexes contain RPS25. Research has shown that knockout of RPS25 increases the 60S/40S and heavy polysome/40S ratios without significantly impairing global translation .
Comparative translation assays: Using reporter constructs with IRES elements or ribosome shunting sequences in wildtype versus RPS25-depleted cells. Studies have demonstrated that RPS25 is essential for translation initiation by the Dicistroviridae and hepatitis C virus IRESs, with knockout cells showing dramatically reduced IRES activity despite minimal effects on cap-dependent translation .
RPS25 has emerged as a critical factor in neurodegenerative disease research, particularly in relation to nucleotide repeat expansion disorders. Research methodologies utilizing RPS25 antibodies include:
Detection of RAN translation products: RPS25 antibodies can be used alongside antibodies against dipeptide repeat proteins (DPRs) to investigate the relationship between RPS25 levels and RAN translation efficiency. Studies have shown that RPS25 knockout reduces poly(GP) levels by approximately 50% and poly(GA) levels by over 90% in C9orf72 repeat expansion models .
Therapeutic target validation: In disease models, researchers have demonstrated that reducing RPS25 levels significantly increases the lifespan of flies expressing pathogenic C9orf72 repeats without affecting control flies . This suggests RPS25 as a potential therapeutic target, which can be further investigated using antibodies for target engagement studies.
Patient-derived cell analysis: In studies using patient-derived induced motor neurons (iMNs), RPS25 antibodies can help evaluate the relationship between RPS25 levels and disease phenotypes, such as the formation of toxic dipeptide repeat protein foci .
RPS25 plays a crucial role in viral translation and replication for multiple viruses that utilize IRES elements or ribosome shunting. Researchers investigating this relationship typically employ these experimental approaches:
Viral replication assays with RPS25 modulation: Studies have shown that viruses utilizing IRES-mediated translation or ribosome shunting (such as hepatitis C virus, poliovirus, or adenovirus) demonstrate impaired amplification in cells depleted of RPS25. In contrast, viruses that rely solely on cap-dependent translation (like herpes simplex virus) replicate normally in the absence of RPS25 .
Structure-function analysis: Using RPS25 antibodies in structural studies (e.g., cryo-EM) to investigate the interaction between RPS25 and viral RNA elements. Research has demonstrated that RPS25 cross-links to the Plautia stali intestine virus (PSIV) IGR IRES in vitro, suggesting direct interaction .
Translation efficiency measurement: Quantifying viral protein synthesis in relation to RPS25 levels using dual reporter assays or metabolic labeling. The experimental design should include controls for cap-dependent translation, which remains largely unaffected by RPS25 depletion .
Investigating ribosome heterogeneity with RPS25 antibodies presents several technical challenges that require sophisticated methodological approaches:
Distinguishing RPS25-containing vs. RPS25-deficient ribosomes: While RPS25 knockout cells can be generated, most cells contain a mixture of ribosomes with and without RPS25. Researchers can use immunoprecipitation followed by mass spectrometry to characterize ribosome populations, but this requires antibodies with high specificity and affinity .
Spatiotemporal resolution of RPS25 incorporation: Understanding when and where RPS25 is incorporated into ribosomes requires advanced imaging techniques such as super-resolution microscopy or proximity ligation assays. Antibody selection for these applications must consider whether epitope accessibility might be affected by ribosome conformation or interaction with other proteins.
Quantitative analysis of RPS25 stoichiometry: Determining the precise stoichiometry of RPS25 in different ribosome populations requires careful calibration of antibody-based detection methods, often using recombinant standards and considering factors like epitope masking in the assembled ribosome.
During viral infection or cellular stress, cells shift from cap-dependent to alternative translation mechanisms. RPS25 antibodies can help investigate this transition through several methodological approaches:
Stress-induced translation profiling: By immunoprecipitating RPS25-containing ribosomes before and after stress induction, researchers can identify mRNAs that specifically require RPS25 under stress conditions. Studies have shown that RPS25 is required for both IRES-mediated translation and ribosome shunting, suggesting these pathways share a common mechanism that differs from cap-dependent translation .
Dual reporter assays: Utilizing reporters for both cap-dependent and IRES/shunt-dependent translation in parallel, researchers can measure the impact of stress on each pathway and the role of RPS25. This allows for the quantification of the translation mode switch during stress and how RPS25 levels influence this process .
Temporal dynamics analysis: By sampling at multiple time points during stress response and recovery, researchers can use RPS25 antibodies to track changes in RPS25-ribosome associations and correlate these with shifts in translation mechanism preference. This methodological approach provides insights into how quickly cells can adapt their translation machinery during stress conditions.
Recent technological advances have expanded our toolkit for studying RPS25 in specialized ribosomes:
CRISPR-mediated tagging: Instead of relying solely on antibodies, researchers are now using CRISPR to add epitope tags or fluorescent proteins to endogenous RPS25, allowing for live-cell tracking and affinity purification of RPS25-containing ribosomes with minimal perturbation to native function .
Proximity-dependent labeling: By fusing RPS25 to enzymes like TurboID or APEX2, researchers can identify proteins that interact with RPS25-containing ribosomes in different cellular compartments or during specific cellular processes, providing spatial information about where specialized translation occurs.
Single-molecule imaging: Advanced microscopy techniques combined with RPS25 antibodies or tagged RPS25 allow visualization of individual ribosomes during translation, revealing the dynamics of RPS25-dependent translation events with unprecedented resolution.
These emerging methodologies complement traditional antibody-based approaches and provide new insights into the specialized functions of RPS25-containing ribosomes.
Research using RPS25 antibodies has revealed important variations in RPS25 function across biological contexts:
Cell-type specific effects: While RPS25 knockout in yeast or Hap1 cells shows only mild effects on global translation and growth , the impact may differ substantially in specialized cells like neurons. In neuronal cells, RPS25-dependent translation may be particularly important for local protein synthesis at synapses or for translation of specific mRNAs critical for neuronal function.
Disease-specific alterations: In C9orf72-related ALS/FTD, RPS25 facilitates the pathogenic RAN translation of repeat expansions . Similar mechanisms may operate in other repeat expansion disorders, such as those involving CAG repeats in ATXN2 and HTT genes. RPS25 antibodies enable comparative studies across different disease models to identify common and distinct mechanisms.
Stress response variations: The dependency on RPS25 for alternative translation mechanisms may vary based on the type of cellular stress (viral infection, oxidative stress, ER stress, etc.) and the specific cell type experiencing the stress . This variation can be systematically mapped using RPS25 antibodies in diverse experimental systems.